Literature DB >> 1419488

Differential up-regulation of specific and azurophilic granule membrane markers in electropermeabilized neutrophils.

H W Niessen1, A J Verhoeven.   

Abstract

We have developed an alternative method to study the degranulation in electropermeabilized human neutrophils by measuring the up-regulation of the specific membrane markers CD63 (residing in the azurophilic granules of resting neutrophils) and CD67 (present in specific granules). The expression of these marker proteins was measured by the binding of specific antibodies to paraformaldehyde-fixed cells and subsequent flow cytometry. We first investigated whether the changes in CD63 and CD67 expression after stimulation of intact cells were comparable with earlier measurements of neutrophil degranulation, in which the release of soluble marker proteins was measured. These experiments indicated that this new method compares favourably with earlier studies, both with respect to kinetics and stimulus dependency. Subsequently, we applied this method (which does not include centrifugation of the cells) to study degranulation in electropermeabilized neutrophils. In permeabilized neutrophils, a clear up-regulation of the specific granule marker CD67 was observed upon incubation with a free Ca2+ concentration of 1 microM, a value of the cytosolic free Ca2+ concentration occurring in formylmethionyl-leucyl-phenylalanine (FMLP)-activated neutrophils. The azurophilic granule marker CD63 required GTP-gamma-S besides 1 microM Ca2+ for a significant up-regulation. Hence, our study indicates a different requirement for intracellular signals of the two main types of granules in human neutrophils.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419488     DOI: 10.1016/0898-6568(92)90019-5

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Tyrosine phosphorylation-dependent activation of phosphatidylinositide 3-kinase occurs upstream of Ca2+-signalling induced by Fcgamma receptor cross-linking in human neutrophils.

Authors:  P J Vossebeld; C H Homburg; R C Schweizer; I Ibarrola; J Kessler; L Koenderman; D Roos; A J Verhoeven
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

2.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.

Authors:  Preston E Bratcher; Steven M Rowe; Ginger Reeves; Tambra Roberts; Tomasz Szul; William T Harris; Rabindra Tirouvanziam; Amit Gaggar
Journal:  J Cyst Fibros       Date:  2015-03-11       Impact factor: 5.482

4.  Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro.

Authors:  J L Teeling; E R De Groot; A J Eerenberg; W K Bleeker; G Van Mierlo; L A Aarden; C E Hack
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

5.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

6.  Intracellular secretory leukoprotease inhibitor modulates inositol 1,4,5-triphosphate generation and exerts an anti-inflammatory effect on neutrophils of individuals with cystic fibrosis and chronic obstructive pulmonary disease.

Authors:  Emer P Reeves; Nessa Banville; Dorothy M Ryan; Niamh O'Reilly; David A Bergin; Kerstin Pohl; Kevin Molloy; Oliver J McElvaney; Khalifah Alsaleh; Ahmed Aljorfi; Osama Kandalaft; Eimear O'Flynn; Patrick Geraghty; Shane J O'Neill; Noel G McElvaney
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

7.  Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

Authors:  Kerstin Pohl; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Matthew J Strand; Jerry A Nick; Preston E Bratcher
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

8.  Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis.

Authors:  Elaine Hayes; Mark P Murphy; Kerstin Pohl; Niall Browne; Karen McQuillan; Le Er Saw; Clare Foley; Fatma Gargoum; Oliver J McElvaney; Padraig Hawkins; Cedric Gunaratnam; Noel G McElvaney; Emer P Reeves
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.